Search hospitals > Ohio > Dayton
Good Samaritan Hospital - Dayton
Claim this profileDayton, Ohio 45406
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cervical Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
353 reported clinical trials
1 medical researcher
Summary
Good Samaritan Hospital - Dayton is a medical facility located in Dayton, Ohio. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Cervical Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Good Samaritan Hospital - Dayton is involved with conducting 353 clinical trials across 437 conditions. There are 1 research doctors associated with this hospital, such as Howard M. Gross.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Clinical Trials running at Good Samaritan Hospital - Dayton
Bladder Cancer
Bladder Carcinoma
Lung Cancer
Kidney Cancer
Parotid Gland Cancer
Non-Small Cell Lung Cancer
Laryngeal Cancer
Multiple Myeloma
Breast Cancer
Cystic Tumor
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
Gemcitabine + Cisplatin
for Bladder Cancer
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting1 award Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Good Samaritan Hospital - Dayton?
Where is Good Samaritan Hospital - Dayton located?
Who should I call to ask about financial aid or insurance network?
What insurance does Good Samaritan Hospital - Dayton accept?
What awards or recognition has Good Samaritan Hospital - Dayton received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.